18
Participants
Start Date
July 29, 2025
Primary Completion Date
December 6, 2026
Study Completion Date
December 7, 2026
BI 3000202_low dose
BI 3000202\_low dose
BI 3000202_high dose
BI 3000202\_high dose
NOT_YET_RECRUITING
UNIV UZ Gent, Ghent
NOT_YET_RECRUITING
Children's Hospital of Philadelphia, Philadelphia
NOT_YET_RECRUITING
ASST degli Spedali Civili di Brescia, Brescia
RECRUITING
Hospital La Paz, Madrid
NOT_YET_RECRUITING
Azienda Sanitaria Universitaria Giuliano Isontina, Trieste
NOT_YET_RECRUITING
HOP Gui de Chauliac, Montpellier
NOT_YET_RECRUITING
Hospital Virgen del Rocío, Seville
NOT_YET_RECRUITING
Universitätsklinikum Tübingen, Tübingen
NOT_YET_RECRUITING
HOP Necker, Paris
NOT_YET_RECRUITING
HOP Tenon, Paris
NOT_YET_RECRUITING
Texas Children's Hospital, Houston
NOT_YET_RECRUITING
Children's Hospital Los Angeles, Los Angeles
NOT_YET_RECRUITING
University of California San Francisco, San Francisco
NOT_YET_RECRUITING
Barzilai Medical Center, Ashkelon
RECRUITING
Universitätsklinikum Carl Gustav Carus Dresden, Dresden
NOT_YET_RECRUITING
ULS de Santa Maria, E.P.E, Lisbon
NOT_YET_RECRUITING
ULS de Santo Antônio, E.P.E - Centro Hospitalar Universitário de Santo António, Porto
NOT_YET_RECRUITING
Hospital Vall d'Hebron, Barcelona
Lead Sponsor
Boehringer Ingelheim
INDUSTRY